Ex-CEO's Counterclaims Not Allowed, Insys Trustee Says
By Ben Zigterman · January 23, 2024, 7:54 PM EST
The liquidation trustee of Insys Therapeutics on Tuesday asked a Delaware bankruptcy judge for an injunction preventing the pharmaceutical company's former CEO Michael L. Babich from pursuing counterclaims in a clawback...
To view the full article, register now.